Company Name Brand Name GMDN Term Name GMDN Term Status FDA Product Code Name FDA Product Code Device Packaged As Sterile Sterilization Prior To Use Issuing Agency Device Size Device Size Type Device Class Implantable

Show Filters

No Description
MICROSURGICAL TECHNOLOGY, INC.
BRT-1025
In Commercial Distribution

  • 00844685003051 ()
BRT-1025

  • Ophthalmic irrigation/infusion/aspiration cannula, non-illuminating, reusable
IMMUNOSUPPRESSANTS QC 3
UTAK LABORATORIES, INC.
025090-0003
In Commercial Distribution

  • B80002509000033 ()
  • B80002509000030 ()

  • Total Volume: 10 Milliliter
IMMU 3 MAYO V2

  • Multiple immunosuppressant therapeutic drug monitoring IVD, control
IMMUNOSUPPRESSANTS QC 2
UTAK LABORATORIES, INC.
025090-0002
In Commercial Distribution

  • B80002509000020 ()
  • B80002509000023 ()

  • Total Volume: 10 Milliliter
IMMU 2 MAYO V2

  • Multiple immunosuppressant therapeutic drug monitoring IVD, control
IMMUNOSUPPRESSANTS QC 1
UTAK LABORATORIES, INC.
025090-0001
In Commercial Distribution

  • B80002509000013 ()
  • B80002509000010 ()

  • Total Volume: 10 Milliliter
IMMU 1 MAYO V2

  • Multiple immunosuppressant therapeutic drug monitoring IVD, control
No Description
INTOUCH TECHNOLOGIES, INC.
Lite Remote Presence System V2
In Commercial Distribution

  • 00868772000150 ()


  • Diagnostic imaging telemedicine system
DNA quantitation and normalization of DNA concentration
Magbio Genomics, Inc.
MagQuant™ Plus DNA V2
In Commercial Distribution

  • 00850045030469 ()
MQP-51920

  • Nucleic acid library construction kit IVD
DNA quantitation and normalization of DNA concentration
Magbio Genomics, Inc.
MagQuant™ Plus DNA V2
In Commercial Distribution

  • 00850045030452 ()
MQP-50384

  • Nucleic acid library construction kit IVD
DNA quantitation and normalization of DNA concentration
Magbio Genomics, Inc.
MagQuant™ Plus DNA V2
In Commercial Distribution

  • 00850045030445 ()
MQP-50096

  • Nucleic acid library construction kit IVD
FENTANYL PLUS LEVEL 3
UTAK LABORATORIES, INC.
FENT+ 3 V2 U NJSP
In Commercial Distribution

  • B800FENT3V2UNJSP5 ()
  • B800FENT3V2UNJSP0 ()

  • Total Volume: 5 Microliter
FENT+ 3 V2 U NJSP

  • Multiple-type clinical chemistry analyte profile IVD, control
FENTANYL PLUS LEVEL 2
UTAK LABORATORIES, INC.
FENT+ 2 V2 U NJSP
In Commercial Distribution

  • B800FENT2V2UNJSP5 ()
  • B800FENT2V2UNJSP0 ()

  • Total Volume: 5 Milliliter
FENT+ 2 V2 U NJSP

  • Multiple-type clinical chemistry analyte profile IVD, control
FENTANYL PLUS LEVEL 1
UTAK LABORATORIES, INC.
FENT+ 1 V2 U NJSP
In Commercial Distribution

  • B800FENT1V2UNJSP5 ()
  • B800FENT1V2UNJSP0 ()

  • Total Volume: 5 Milliliter
FENT+ 1 V2 U NJSP

  • Multiple-type clinical chemistry analyte profile IVD, control
ETGCALV2MLB
UTAK LABORATORIES, INC.
ETG CAL V2 M LB
In Commercial Distribution

  • B800ETGCALV2MLB5 ()
  • B800ETGCALV2MLB0 ()

  • Total Volume: 0.5 Milliliter
ETG CAL V2 M LB

  • Multiple-type clinical chemistry analyte profile IVD, control
DRUGS OF ABUSE 3
UTAK LABORATORIES, INC.
DA WB 3 V2 OCME
In Commercial Distribution

  • B800DAWB3V2OCME5 ()
  • B800DAWB3V2OCME0 ()

  • Total Volume: 10 Milliliter
DA WB 3 V2 OCME

  • Multiple-type clinical chemistry analyte profile IVD, control
DAU LOW
UTAK LABORATORIES, INC.
DAU V2 L QC SH
In Commercial Distribution

  • B800DAUV2LQCSH5 ()
  • B800DAUV2LQCSH0 ()

  • Total Volume: 3 Milliliter
DAU V2 L QC SH

  • Multiple drugs of abuse IVD, control
DAU HIGH
UTAK LABORATORIES, INC.
DAU V2 H QC SH
In Commercial Distribution

  • B800DAUV2HQCSH5 ()
  • B800DAUV2HQCSH0 ()

  • Total Volume: 3 Milliliter
DAU V2 H QC SH

  • Multiple drugs of abuse IVD, control
DAU QC KIT
UTAK LABORATORIES, INC.
DAU QC KIT V2 ABS
In Commercial Distribution

  • B800DAUQCKITV2ABS0 ()

  • Total Volume: 10 Milliliter
DAU QC KIT V2 ABS

  • Multiple drugs of abuse IVD, control
DAU POSITIVE
UTAK LABORATORIES, INC.
DAU POS V2 F CH
In Commercial Distribution

  • B800DAUPOSV2FCH5 ()
  • B800DAUPOSV2FCH0 ()

  • Total Volume: 10 Milliliter
DAU POS V2 F CH

  • Multiple-type clinical chemistry analyte profile IVD, control
DAU NEGATIVE
UTAK LABORATORIES, INC.
DAU NEG V2 F CH
In Commercial Distribution

  • B800DAUNEGV2FCH5 ()
  • B800DAUNEGV2FCH0 ()

  • Total Volume: 10 Milliliter
DAU NEG V2 F CH

  • Multiple-type clinical chemistry analyte profile IVD, control
DRUGS OF ABUSE MID
UTAK LABORATORIES, INC.
DAU M V2 F UPHS
In Commercial Distribution

  • B800DAUMV2FUPHS5 ()
  • B800DAUMV2FUPHS0 ()

  • Total Volume: 2 Milliliter
DAU M V2 F UPHS

  • Multiple-type clinical chemistry analyte profile IVD, control
DRUGS OF ABUSE LOW
UTAK LABORATORIES, INC.
DAU L V2 F UPHS
In Commercial Distribution

  • B800DAULV2FUPHS5 ()
  • B800DAULV2FUPHS0 ()

  • Total Volume: 2 Milliliter
DAU L V2 F UPHS

  • Multiple-type clinical chemistry analyte profile IVD, control
DRUGS OF ABUSE LOW
UTAK LABORATORIES, INC.
DAU L V2 F MAYO
In Commercial Distribution

  • B800DAULV2FMAYO5 ()
  • B800DAULV2FMAYO0 ()

  • Total Volume: 25 Milliliter
DAU L V2 F MAYO

  • Multiple-type clinical chemistry analyte profile IVD, control
DRUGS OF ABUSE HIGH
UTAK LABORATORIES, INC.
DAU H V2 F UPHS
In Commercial Distribution

  • B800DAUHV2FUPHS5 ()
  • B800DAUHV2FUPHS0 ()

  • Total Volume: 2 Milliliter
DAU H V2 F UPHS

  • Multiple-type clinical chemistry analyte profile IVD, control
DRUGS OF ABUSE HIGH
UTAK LABORATORIES, INC.
DAU H V2 F MAYO
In Commercial Distribution

  • B800DAUHV2FMAYO5 ()
  • B800DAUHV2FMAYO0 ()

  • Total Volume: 25 Milliliter
DAU H V2 F MAYO

  • Multiple-type clinical chemistry analyte profile IVD, control
DRUGS OF ABUSE SCREENING LEVEL 2
UTAK LABORATORIES, INC.
DAU 2 V2 IA QC
In Commercial Distribution

  • B800DAU2V2IAQC5 ()
  • B800DAU2V2IAQC0 ()

  • Total Volume: 20 Milliliter
DAU 2 V2 IA QC

  • Multiple-type clinical chemistry analyte profile IVD, control
DRUGS OF ABUSE LEVEL 2
UTAK LABORATORIES, INC.
DAU 2 V2 F APS
In Commercial Distribution

  • B800DAU2V2FAPS5 ()
  • B800DAU2V2FAPS0 ()

  • Total Volume: 10 Milliliter
DAU 2 V2 F APS

  • Multiple drugs of abuse IVD, control
DAU2FV2P2L
UTAK LABORATORIES, INC.
DAU 2 F V2 P2L
In Commercial Distribution

  • B800DAU2FV2P2L5 ()
  • B800DAU2FV2P2L0 ()

  • Total Volume: 50 Milliliter
DAU 2 F V2 P2L

  • Multiple-type clinical chemistry analyte profile IVD, control
DRUGS OF ABUSE SCREENING LEVEL 1
UTAK LABORATORIES, INC.
DAU 1 V2 IA QC
In Commercial Distribution

  • B800DAU1V2IAQC5 ()
  • B800DAU1V2IAQC0 ()

  • Total Volume: 20 Milliliter
DAU 1 V2 IA QC

  • Multiple-type clinical chemistry analyte profile IVD, control
DAU LEVEL 1
UTAK LABORATORIES, INC.
DAU 1 V2 F SMA
In Commercial Distribution

  • B800DAU1V2FSMA5 ()
  • B800DAU1V2FSMA0 ()

  • Total Volume: 5 Milliliter
DAU 1 V2 F SMA

  • Multiple drugs of abuse IVD, control
DRUGS OF ABUSE LEVEL 1
UTAK LABORATORIES, INC.
DAU 1 V2 F APS
In Commercial Distribution

  • B800DAU1V2FAPS5 ()
  • B800DAU1V2FAPS0 ()

  • Total Volume: 10 Milliliter
DAU 1 V2 F APS

  • Multiple drugs of abuse IVD, control
DAU LEVEL 1
UTAK LABORATORIES, INC.
DAU 1 F V2 UTMB
In Commercial Distribution

  • B800DAU1FV2UTMB5 ()
  • B800DAU1FV2UTMB0 ()

  • Total Volume: 2 Milliliter
DAU 1 F V2 UTMB

  • Multiple drugs of abuse IVD, control
DAU1FV2P2L
UTAK LABORATORIES, INC.
DAU 1 F V2 P2L
In Commercial Distribution

  • B800DAU1FV2P2L5 ()
  • B800DAU1FV2P2L0 ()

  • Total Volume: 50 Milliliter
DAU 1 F V2 P2L

  • Multiple-type clinical chemistry analyte profile IVD, control
DRUGS OF ABUSE PLUS LEVEL 4
UTAK LABORATORIES, INC.
DA+4 WB V2 IMMUN
In Commercial Distribution

  • B800DA4WBV2IMMUN5 ()
  • B800DA4WBV2IMMUN0 ()

  • Total Volume: 1 Milliliter
DA+4 WB V2 IMMUN

  • Multiple therapeutic drugs/drugs of abuse IVD, control
BENZODIAZEPINES LEVEL 2
UTAK LABORATORIES, INC.
BENZO 2 V2 U KP
In Commercial Distribution

  • B800BENZO2V2UKP5 ()
  • B800BENZO2V2UKP0 ()

  • Total Volume: 3 Milliliter
BENZO 2 V2 U KP

  • Multiple-type clinical chemistry analyte profile IVD, control
ANTIPSYCHOTICS URINE PLUS
UTAK LABORATORIES, INC.
ANTIPSYCH+ V2 U F OT
In Commercial Distribution

  • B800ANTIPSYCHV2UFOT5 ()
  • B800ANTIPSYCHV2UFOT0 ()

  • Total Volume: 1 Milliliter
ANTIPSYCH+ V2 U F OT

  • Multiple-type clinical chemistry analyte profile IVD, control
AMITRIPTYLINE PLUS
UTAK LABORATORIES, INC.
AMIT+ V2 U F BRL
In Commercial Distribution

  • B800AMITV2UFBRL5 ()
  • B800AMITV2UFBRL0 ()

  • Total Volume: 2 Milliliter
AMIT+ V2 U F BRL

  • Multiple therapeutic drugs/drugs of abuse IVD, control
ALPRAZOLAM PLUS 2
UTAK LABORATORIES, INC.
ALP+ 2 V2 S SH
In Commercial Distribution

  • B800ALP2V2SSH0 ()

  • Total Volume: 3 Milliliter
ALP+ 2 V2 S SH

  • Multiple-type clinical chemistry analyte profile IVD, control
ALPRAZOLAM PLUS 1
UTAK LABORATORIES, INC.
ALP+ 1 V2 S SH
In Commercial Distribution

  • B800ALP1V2SSH5 ()
  • B800ALP1V2SSH0 ()

  • Total Volume: 3 Milliliter
ALP+ 1 V2 S SH

  • Multiple-type clinical chemistry analyte profile IVD, control
AED PLUS HIGH
UTAK LABORATORIES, INC.
AED+ H S V2 SCH
In Commercial Distribution

  • B800AEDHSV2SCH5 ()
  • B800AEDHSV2SCH0 ()

  • Total Volume: 5 Liter
AED+ H S V2 SCH

  • Multiple-type clinical chemistry analyte profile IVD, control
No Description
UTAK LABORATORIES, INC.
U QC HIGH V2 EL
In Commercial Distribution

  • B80001390500040 ()
  • B80001390500041 ()
  • B80001390500042 ()
  • B80001390500043 ()
  • B80001390500046 ()
  • B80001390500047 ()
  • B80001390500048 ()


  • Multiple therapeutic drugs/drugs of abuse IVD, control
No Description
UTAK LABORATORIES, INC.
U QC LOW V2 EL
In Commercial Distribution

  • B80001390500030 ()
  • B80001390500031 ()
  • B80001390500032 ()
  • B80001390500033 ()
  • B80001390500036 ()
  • B80001390500037 ()
  • B80001390500038 ()


  • Multiple therapeutic drugs/drugs of abuse IVD, control
< 1 ... 51 52 53 54 55 56 >